Table 3.
Top 20 differentially expressed transcripts between female African American patients with SSc and controls ranked by absolute effect size
| Gene | Chr | Start (kb) | End (kb) | Strand | logFC | logCPM | p Value | Adjusted p value |
|---|---|---|---|---|---|---|---|---|
| COL9A2 | 1 | 40,766 | 40,883 | − | − 1.18 | 3.04 | 1.26E−04 | 0.25 |
| OBSCN | 1 | 228,296 | 228,495 | + | − 1.13 | 2.13 | 5.01E−04 | 0.25 |
| PPP1R14B | 11 | 64,012 | 64,114 | − | − 0.65 | 2.53 | 2.17E−04 | 0.25 |
| GDAP1 | 8 | 75,163 | 75,279 | + | 0.57 | 4.1 | 3.66E−04 | 0.25 |
| TMC8 | 17 | 76,027 | 76,139 | + | − 0.54 | 6.38 | 5.50E−05 | 0.25 |
| ZNF654 | 3 | 88,088 | 88,194 | + | 0.43 | 4.19 | 2.37E−04 | 0.25 |
| KYNU | 2 | 143,535 | 143,735 | + | 0.43 | 7.52 | 3.25E−04 | 0.25 |
| KLF6 | 10 | 3818 | 3927 | − | 0.42 | 9.52 | 1.94E−04 | 0.25 |
| INSIG2 | 2 | 118,746 | 118,868 | + | 0.41 | 3.65 | 2.79E−04 | 0.25 |
| SLC35B3 | 6 | 8,413 | 8,536 | − | 0.41 | 4.39 | 3.10E−04 | 0.25 |
| POT1 | 7 | 124,470 | 124,670 | − | 0.41 | 4.64 | 4.27E−04 | 0.25 |
| HIVEP3 | 1 | 42,284 | 42,484 | − | − 0.4 | 5.13 | 2.65E−04 | 0.25 |
| HPSE | 4 | 84,216 | 84,356 | − | 0.4 | 6.6 | 6.95E−05 | 0.25 |
| MDM2 | 12 | 69,102 | 69,239 | + | 0.37 | 7.08 | 1.42E−04 | 0.25 |
| ABHD5 | 3 | 43,632 | 43,764 | + | 0.36 | 5.8 | 4.49E−04 | 0.25 |
| RNF146 | 6 | 127,488 | 127,610 | + | 0.36 | 5.85 | 4.66E−04 | 0.25 |
| IVD | 15 | 40,598 | 40,714 | + | − 0.34 | 5.67 | 2.20E−04 | 0.25 |
| SMARCA4 | 19 | 10,972 | 11,172 | + | − 0.31 | 7.93 | 2.97E−04 | 0.25 |
| PLD1 | 3 | 171,428 | 171,628 | − | 0.27 | 5.99 | 1.78E−04 | 0.25 |
| CYTH4 | 22 | 37,578 | 37,711 | + | − 0.26 | 7.88 | 1.71E−04 | 0.25 |
Genes are shown, along with location, strand, logarithm fold change (logFC), logarithm of counts per million reads (logCPM), unadjusted and adjusted p values